#Canada #Greenway Cannabis #Kingsville #cannabis cultivation #International Expansion

Greenway Greenhouse Cannabis Corporation: 2025 Year in Review

Overview of Progress

In a year marked by challenges and growth opportunities, Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) has illustrated a strong commitment to operational excellence and strategic advancements. With its headquarters in Kingsville, Ontario, Greenway has been a significant player in the Canadian cannabis market, sustaining high-quality greenhouse cultivation.

Operational Excellence

Throughout 2025, Greenway focused on optimizing its existing 2.5 acres of active cultivation. The results were impressive: improved yields coupled with effective cost controls allowed for consistent production planning. Key strategies included refined crop scheduling and strain selection—an emphasis on efficiency that management believes has established a durable foundation for future profitability.

The company's operational adjustments are not mere short-term fixes; they have been designed to create lasting change enhancing overall efficiency. This focus is expected to be crucial as Greenway prepares for further growth in strategically advantageous markets.

Expansion into International Markets

A significant achievement for Greenway in 2025 was the introduction of its international wholesale program. The company's cannabis products began to reach various jurisdictions in Europe and Australia, catering to an expanding global medical cannabis demand. Greenway's efforts in these markets demonstrate its ability to navigate complex regulatory and compliance landscapes, thus setting itself apart from competitors.

Notably, Greenway entered into a strategic supply agreement with 4C Labs in the United Kingdom, exclusively targeting the U.K. medical cannabis market. This strategic move not only positions Greenway favorably within the European landscape but also reflects the company’s broader commitment to diversify its international sales channels.

Anticipating Future Growth

Looking ahead, Greenway sees considerable potential for revenue growth through the utilization of its recently expanded cultivation capacities. With additional space already built, the company is poised to increase production without incurring significant capital expenditures, projecting a growth in capabilities by more than 75%.

Greenway's leadership team brings substantial experience in large-scale commercial agriculture, enabling it to scale production effectively while maintaining cost efficiency. This strategy aims to support higher production volumes, thereby enhancing revenue while keeping the cost structure disciplined.

Leadership Insights

Jamie D'Alimonte, CEO of Greenway, noted, "2025 was a year of meaningful progress for Greenway across several fronts. We observed a 20% increase in total revenue, coupled with a 40% enhancement in our average selling price per gram, affirming both the rising demand and the quality of our offerings."

As demand continues to evolve, Greenway is set to bring its built-out cultivation capacity into action in a controlled manner. The company is optimistic that leveraging its existing capabilities will allow for an increase in output without compromising cost efficiency, paving the way for greater margins and enhanced profitability as it progresses.

Market Outlook

As the cannabis sector faces ongoing pricing pressures and market dynamics, Greenway remains steadfast in its approach. The company's focus on disciplined execution and capital management positions it well to navigate these complexities. Furthermore, management anticipates that 2026 will reap the benefits of the groundwork laid during the past year, showcasing Greenway's potential to capitalize on the expansive opportunities within the global medical cannabis market.

Conclusion

In summary, 2025 has been pivotal for Greenway Greenhouse Cannabis Corporation, demonstrating its ability to adapt and thrive in a competitive market landscape. With a robust operational foundation, strategic international partnerships, and plans for future capacity utilization, Greenway is strategically aligned to enhance its position as a leading cannabis cultivator in Canada and beyond. This comprehensive review underscores the company's commitment to growth, quality, and market leadership as it moves forward into 2026 and further into the global cannabis marketplace.